The Latest

• Members of Congress request MOU extension

  16 members of the US House of Representatives have sent a letter to Acting FDA Commissioner Janet Woodcock asking FDA to extend the deadline for signing the interstate-shipment MOU. • Read more →

• cBHT campaign: THIS close to completion, but stalled

  If cBHT is part of your compounding business and you haven’t yet contributed to help APC protect it — please, think like a business owner. • Read more →

• Don’t you hate being ALMOST good enough? (Us too.)

  We’re so close, so close, we can taste victory. But that's just not close enough. APC is still about $290,000 short of being able to get our campaign to protect cBHT to a national audience. • Read more →

• 4 things to know about APC’s cBHT media campaign

  Here's a quick update on where we stand — and what we've accomplished so far — with the cBHT media campaign. • Read more →

• Know them? Nudge them

  Everybody who’s anybody is a member of APC, right? Well, not quite. • Read more →

• Reuben answers the call

  We asked you to blog for Compounding.com, and Reuben Nielsen of MedQuest Pharmacy in North Salt Lake, Utah, responded. • Read more →

• Psych out

  Informa is offering a free webinar, "Psychedelics in CNS Therapeutics: Why Interest is Surging and What to Expect Next" on July 20 at 11:00 am EDT. Click the link for info and to register. • Read more →

• Scott to present at The Compounders Group

  APC CEO Scott Brunner will be presenting at The Compounders Group Members Only Seminar later this month: at the Hotel Chicago, July 22-24. • Read more →

• Letco Med offers two-pronged support for cBHT campaign

  Letco Med is supporting our cBHT media campaign in two big ways. • Read more →

• Media campaign now only $325,000 short

  Thanks to Medisca's generous matching program, our cBHT media campaign is closer to its goal — but still $325K short. • Read more →

Thank you to Daved Rosensweet, MD

… for writing about the threat to compounded hormones in Townsend Letter: “If We Lose Compounded Bioidentical Hormone Replacement Therapy“